Nifty

:

24435.95

Sensex

:

77966.35

-35.75 (-0.15%)
-187.90 (-0.24%)

Login

Nifty
Sensex

:
:

24435.95
77966.35

-35.75 (-0.15%)
-187.90 (-0.24%)

Cohance Lifesciences Ltd.

Pharmaceuticals & Drugs - Global

Rating :

38/99

BSE: 543064 | NSE: COHANCE

Watchlist

NSE BSE

444.35

12-Aug-2026

Open
High
Low
Previous Close

465
468.35
443
463.95

Volume
Traded Value (lacs)
52 Week High
52 Week Low

517907
233342256
1038.9
266.7

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17,006.45
160.09
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

17,081.70
N/A
4.40

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
3.47
-3.68

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-3.27
-8.16

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-5.86
-13.32

P:E (Median)

8 Years
5 Years
3 Years

-
43.02
90.87

P:BV (Average)

8 Years
5 Years
3 Years

-
10.00
11.07

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
39.42
51.33

Earnings Forecasts:

(Updated: 08-08-2026)

Description 2026 2027 2028 2029
Adj EPS 23 5 36.53 6.98
P/E Ratio 19.32 88.87 12.16 63.66
Revenue 51.43 34.78 31.74 2330.16
EBITDA 2628.94 3107.14 3595.72 535.7
Net Income 654.04 844.37 931.12 217.05
ROA 335.98 494.27 667.03 11.76
P/B Ratio -2.27 -62.58 - 4.93
ROE 4.14 3.7 3.45 9.36
FCFF 8.13 10.28 18.04 140.43
FCFF Yield 119.38 148.2 3291.73 0.8
Net Debt 0.68 0.85 18.8 -323.5
BVPS -195.5 -7.1 - 90.17

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 359.89 483.58 -25.58% 567.55 768.57 -26.16% 481.58 653.35 -26.29% 497.79 594.43 -16.26%
Expenses 333.40 379.38 -12.12% 450.98 545.80 -17.37% 378.80 420.60 -9.94% 366.93 390.91 -6.13%
EBITDA 26.49 104.20 -74.58% 116.57 222.77 -47.67% 102.78 232.75 -55.84% 130.86 203.52 -35.70%
EBIDTM 7.36% 21.55% 20.54% 28.98% 21.34% 35.62% 26.29% 34.24%
Other Income 12.16 13.10 -7.18% -0.79 8.19 - 6.12 21.48 -71.51% 26.30 15.76 66.88%
Interest 2.12 6.80 -68.82% 5.17 7.00 -26.14% 5.25 10.08 -47.92% 5.24 9.42 -44.37%
Depreciation 34.32 31.36 9.44% 37.66 42.58 -11.55% 33.36 38.09 -12.42% 31.20 34.56 -9.72%
PBT 2.21 71.04 -96.89% 56.44 165.60 -65.92% 65.43 206.06 -68.25% 120.72 175.30 -31.14%
Tax 0.80 18.47 -95.67% 21.88 42.83 -48.91% 18.14 52.20 -65.25% 26.43 36.20 -26.99%
PAT 1.41 52.57 -97.32% 34.56 122.77 -71.85% 47.29 153.86 -69.26% 94.29 139.10 -32.21%
PATM 0.39% 10.87% 6.09% 15.97% 9.82% 23.55% 18.94% 23.40%
EPS 0.04 1.37 -97.08% 0.90 3.21 -71.96% 1.24 4.02 -69.15% 2.46 3.64 -32.42%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 422.26 549.31 -23.13% 619.12 840.42 -26.33% 544.55 676.23 -19.47% 555.57 603.77 -7.98%
Expenses 421.10 437.30 -3.70% 520.44 611.20 -14.85% 449.20 438.86 2.36% 434.62 398.40 9.09%
EBITDA 1.16 112.01 -98.96% 98.68 229.22 -56.95% 95.35 237.37 -59.83% 120.95 205.37 -41.11%
EBIDTM 0.27% 20.39% 15.94% 27.27% 17.51% 35.10% 21.77% 34.01%
Other Income 12.25 14.17 -13.55% -1.84 12.05 - 6.16 21.56 -71.43% 15.60 16.19 -3.64%
Interest 6.74 10.18 -33.79% 9.19 10.45 -12.06% 9.11 10.80 -15.65% 8.76 9.61 -8.84%
Depreciation 49.54 45.14 9.75% 51.23 54.17 -5.43% 46.94 43.56 7.76% 44.02 37.79 16.49%
PBT -42.87 62.76 - 19.91 160.87 -87.62% 40.60 204.57 -80.15% 83.77 174.16 -51.90%
Tax 2.32 16.36 -85.82% 11.60 43.72 -73.47% 11.58 51.09 -77.33% 17.38 35.92 -51.61%
PAT -45.19 46.40 - 8.31 117.15 -92.91% 29.02 153.48 -81.09% 66.39 138.24 -51.97%
PATM -10.70% 8.45% 1.34% 13.94% 5.33% 22.70% 11.95% 22.90%
EPS -0.63 1.28 - 0.51 4.73 -89.22% 0.96 6.01 -84.03% 1.94 5.44 -64.34%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 1,906.81 1,093.51 1,051.35 1,330.08 1,320.22 1,009.72 833.79 377.83 Net Sales Growth -23.73% 4.01% -20.96% 0.75% 30.75% 21.10% 120.68% Cost Of Goods Sold 617.27 294.49 311.39 394.26 394.05 297.56 225.32 101.46 Gross Profit 1,289.54 799.02 739.96 935.83 926.17 712.16 608.47 276.37 GP Margin 67.63% 73.07% 70.38% 70.36% 70.15% 70.53% 72.98% 73.15% Total Expenditure 1,530.11 730.94 645.49 739.39 737.94 566.68 449.00 206.28 Power & Fuel Cost - 42.19 48.30 71.35 59.55 44.20 38.23 18.06 % Of Sales - 3.86% 4.59% 5.36% 4.51% 4.38% 4.59% 4.78% Employee Cost - 198.30 135.23 108.58 100.48 76.23 65.10 29.63 % Of Sales - 18.13% 12.86% 8.16% 7.61% 7.55% 7.81% 7.84% Manufacturing Exp. - 86.00 88.85 106.75 129.24 105.31 83.89 35.11 % Of Sales - 7.86% 8.45% 8.03% 9.79% 10.43% 10.06% 9.29% General & Admin Exp. - 35.67 27.05 31.13 28.43 27.69 25.93 12.62 % Of Sales - 3.26% 2.57% 2.34% 2.15% 2.74% 3.11% 3.34% Selling & Distn. Exp. - 12.17 10.46 17.43 19.80 10.53 9.43 6.72 % Of Sales - 1.11% 0.99% 1.31% 1.50% 1.04% 1.13% 1.78% Miscellaneous Exp. - 62.12 24.21 9.90 6.37 5.16 1.08 2.69 % Of Sales - 5.68% 2.30% 0.74% 0.48% 0.51% 0.13% 0.71% EBITDA 376.70 362.57 405.86 590.69 582.28 443.04 384.79 171.55 EBITDA Margin 19.76% 33.16% 38.60% 44.41% 44.10% 43.88% 46.15% 45.40% Other Income 43.79 53.98 56.61 44.55 187.79 14.24 18.12 0.60 Interest 17.78 8.00 7.45 12.75 8.53 11.66 21.81 2.79 Depreciation 136.54 57.20 54.60 43.10 39.10 31.64 23.51 11.50 PBT 244.80 351.35 400.42 579.39 722.45 413.98 357.59 157.87 Tax 67.25 79.64 103.95 146.79 164.35 105.33 87.51 48.59 Tax Rate 27.47% 22.67% 25.96% 25.34% 22.75% 25.44% 24.47% 30.78% PAT 177.55 271.71 296.47 432.60 558.10 308.65 270.08 109.27 PAT before Minority Interest 177.55 271.71 296.47 432.60 558.10 308.65 270.08 109.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.31% 24.85% 28.20% 32.52% 42.27% 30.57% 32.39% 28.92% PAT Growth -62.09% -8.35% -31.47% -22.49% 80.82% 14.28% 147.17% EPS 4.64 7.10 7.75 11.31 14.59 8.07 7.06 2.86

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 2,141.50 1,197.58 1,051.35 1,340.33 1,320.22 1,009.72 833.79 377.83 Net Sales Growth -19.79% 13.91% -21.56% 1.52% 30.75% 21.10% 120.68% Cost Of Goods Sold 634.77 300.73 311.86 402.97 394.05 297.56 225.32 101.46 Gross Profit 1,506.73 896.85 739.49 937.36 926.17 712.16 608.47 276.37 GP Margin 70.36% 74.89% 70.34% 69.94% 70.15% 70.53% 72.98% 73.15% Total Expenditure 1,825.36 822.38 645.54 766.17 738.50 566.72 449.03 206.28 Power & Fuel Cost - 47.29 48.30 73.93 59.55 44.20 38.23 18.06 % Of Sales - 3.95% 4.59% 5.52% 4.51% 4.38% 4.59% 4.78% Employee Cost - 249.56 135.23 118.25 100.48 76.23 65.10 29.63 % Of Sales - 20.84% 12.86% 8.82% 7.61% 7.55% 7.81% 7.84% Manufacturing Exp. - 102.96 88.37 109.62 129.24 105.31 83.89 35.11 % Of Sales - 8.60% 8.41% 8.18% 9.79% 10.43% 10.06% 9.29% General & Admin Exp. - 45.34 27.11 33.87 28.99 27.73 25.97 12.62 % Of Sales - 3.79% 2.58% 2.53% 2.20% 2.75% 3.11% 3.34% Selling & Distn. Exp. - 14.32 10.46 17.64 19.80 10.53 9.43 6.72 % Of Sales - 1.20% 0.99% 1.32% 1.50% 1.04% 1.13% 1.78% Miscellaneous Exp. - 62.18 24.21 9.90 6.37 5.16 1.08 2.69 % Of Sales - 5.19% 2.30% 0.74% 0.48% 0.51% 0.13% 0.71% EBITDA 316.14 375.20 405.81 574.16 581.72 443.00 384.76 171.55 EBITDA Margin 14.76% 31.33% 38.60% 42.84% 44.06% 43.87% 46.15% 45.40% Other Income 32.17 58.56 61.91 46.36 92.38 14.24 18.12 0.60 Interest 33.80 12.35 7.45 12.81 8.53 11.67 23.07 2.79 Depreciation 191.73 77.49 54.60 47.99 39.10 31.64 23.51 11.50 PBT 101.41 343.92 405.67 559.73 626.48 413.94 356.30 157.87 Tax 42.88 79.15 105.39 148.44 213.78 105.33 87.51 48.59 Tax Rate 42.28% 23.01% 25.98% 26.52% 34.12% 25.45% 24.56% 30.78% PAT 58.53 267.87 300.28 411.29 453.80 362.34 317.00 109.27 PAT before Minority Interest 106.23 264.77 300.28 411.29 453.80 362.34 317.00 109.27 Minority Interest 47.70 3.10 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.73% 22.37% 28.56% 30.69% 34.37% 35.89% 38.02% 28.92% PAT Growth -87.14% -10.79% -26.99% -9.37% 25.24% 14.30% 190.11% EPS 1.53 7.00 7.85 10.75 11.86 9.47 8.29 2.86

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 2,315.55 2,028.35 1,749.38 1,520.69 1,065.18 782.83 590.29 Share Capital 25.46 25.46 25.46 25.46 25.46 12.73 0.00 Total Reserves 2,273.20 2,000.92 1,723.92 1,495.24 1,039.73 770.10 577.56 Non-Current Liabilities 58.73 68.57 54.77 75.19 73.91 127.68 35.12 Secured Loans 0.00 0.00 4.56 28.44 35.59 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 91.25 0.00 Long Term Provisions 0.00 0.00 7.87 8.89 6.65 8.31 5.95 Current Liabilities 213.53 117.15 298.50 346.23 321.49 319.85 190.67 Trade Payables 71.03 42.25 66.89 105.90 82.93 71.06 53.57 Other Current Liabilities 56.19 21.28 18.53 28.25 28.56 27.51 19.47 Short Term Borrowings 70.00 38.58 64.60 67.13 105.64 94.04 82.79 Short Term Provisions 16.31 15.04 148.48 144.94 104.36 127.24 34.83 Total Liabilities 2,587.81 2,214.07 2,102.65 1,942.11 1,460.58 1,230.36 816.08 Net Block 684.79 669.62 512.03 534.19 441.16 356.74 270.90 Gross Block 996.62 928.90 713.00 693.81 569.62 456.66 347.41 Accumulated Depreciation 311.83 259.28 200.98 159.62 128.46 99.91 76.51 Non Current Assets 1,879.05 989.84 1,003.21 695.93 794.13 719.36 393.28 Capital Work in Progress 253.93 179.08 164.81 29.99 96.32 101.71 111.07 Non Current Investment 924.64 118.67 317.21 118.67 245.65 245.65 0.07 Long Term Loans & Adv. 15.69 22.47 9.16 13.07 10.85 15.06 11.02 Other Non Current Assets 0.00 0.00 0.00 0.00 0.16 0.20 0.22 Current Assets 708.76 1,224.23 1,099.44 1,246.19 666.45 511.00 422.80 Current Investments 191.56 773.90 392.85 481.22 180.59 30.67 7.06 Inventories 154.12 231.20 311.47 283.42 201.08 174.87 157.10 Sundry Debtors 242.47 133.66 109.66 236.37 102.38 117.20 147.50 Cash & Bank 22.62 21.73 46.23 32.95 9.56 13.96 12.90 Other Current Assets 97.99 11.90 10.73 10.87 172.83 174.30 98.24 Short Term Loans & Adv. 87.57 51.84 228.50 201.35 161.00 165.17 85.18 Net Current Assets 495.23 1,107.08 800.94 899.96 344.96 191.15 232.13 Total Assets 2,587.81 2,214.07 2,102.65 1,942.12 1,460.58 1,230.36 816.08

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 1,696.58 2,050.67 1,735.18 1,527.18 1,180.81 844.76 590.29 Share Capital 25.46 25.46 25.46 25.46 25.46 12.73 0.00 Total Reserves 1,654.23 2,023.24 1,709.73 1,501.72 1,155.35 832.03 577.56 Non-Current Liabilities 825.37 86.03 71.79 92.11 73.91 127.68 35.12 Secured Loans 6.24 0.00 4.56 28.44 35.59 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 91.25 0.00 Long Term Provisions 0.26 0.00 8.30 8.89 6.65 8.31 5.95 Current Liabilities 365.19 117.40 303.09 347.52 321.51 319.85 190.67 Trade Payables 80.21 42.35 70.09 105.90 82.93 71.06 53.57 Other Current Liabilities 196.01 21.23 19.84 29.54 28.57 27.51 19.47 Short Term Borrowings 70.00 38.58 64.60 67.13 105.64 94.04 82.79 Short Term Provisions 18.97 15.24 148.56 144.94 104.36 127.24 34.83 Total Liabilities 3,031.20 2,254.10 2,110.06 1,966.81 1,576.23 1,292.29 816.08 Net Block 1,713.42 669.62 663.33 534.19 441.16 356.74 270.90 Gross Block 2,045.63 929.16 875.60 693.81 569.62 456.66 347.41 Accumulated Depreciation 332.21 259.54 212.27 159.62 128.46 99.91 76.51 Non Current Assets 2,142.61 1,000.89 954.70 701.66 909.68 781.17 393.28 Capital Work in Progress 255.61 179.08 165.09 29.99 96.32 101.71 111.07 Non Current Investment 144.95 130.58 117.10 117.10 361.19 307.46 0.07 Long Term Loans & Adv. 24.05 21.61 9.19 13.07 10.85 15.06 11.02 Other Non Current Assets 4.58 0.00 0.00 7.30 0.16 0.20 0.22 Current Assets 853.28 1,253.21 1,155.37 1,265.16 666.54 511.12 422.80 Current Investments 191.74 773.90 418.94 481.22 180.59 30.67 7.06 Inventories 166.57 231.20 312.81 283.42 201.08 174.87 157.10 Sundry Debtors 284.44 133.66 110.94 236.37 102.38 117.20 147.50 Cash & Bank 88.67 50.50 68.01 47.31 9.65 14.07 12.90 Other Current Assets 121.86 11.90 11.46 10.87 172.83 174.30 98.24 Short Term Loans & Adv. 106.60 52.05 233.21 205.97 161.00 165.17 85.18 Net Current Assets 488.09 1,135.81 852.28 917.64 345.04 191.27 232.13 Total Assets 2,995.89 2,254.10 2,110.07 1,966.82 1,576.22 1,292.29 816.08

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 301.03 376.20 492.82 269.89 328.84 358.75 50.40 PBT 351.35 400.42 579.39 722.45 413.98 357.59 157.87 Adjustment 41.23 17.14 35.68 -110.18 36.48 33.35 13.93 Changes in Working Capital -11.17 67.16 23.53 -190.63 -12.19 54.22 -88.33 Cash after chg. in Working capital 381.41 484.72 638.61 421.64 438.27 445.16 83.47 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -80.38 -108.52 -145.79 -151.74 -109.44 -86.41 -33.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -320.94 -362.40 -236.86 -90.30 -257.66 -366.65 -65.48 Net Fixed Assets -142.57 -230.17 -154.01 -57.86 -107.57 -99.89 Net Investments -223.63 -182.51 -110.17 -173.65 -149.92 -269.19 Others 45.26 50.28 27.32 141.21 -0.17 2.43 Cash from Financing Activity 20.81 -39.99 -243.14 -156.48 -75.66 8.58 25.98 Net Cash Inflow / Outflow 0.90 -26.19 12.81 23.12 -4.49 0.67 10.90 Opening Cash & Equivalents 18.46 44.65 30.21 7.09 11.58 10.90 0.00 Closing Cash & Equivalent 19.36 18.46 43.02 30.21 7.09 11.58 10.90

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 288.16 384.77 457.20 330.00 382.55 406.92 50.40 PBT 343.92 405.67 559.73 667.59 467.67 404.51 157.87 Adjustment 59.82 17.14 37.46 40.63 36.48 34.60 13.93 Changes in Working Capital -32.14 71.91 5.77 -193.97 -12.17 54.21 -88.33 Cash after chg. in Working capital 371.60 494.72 602.96 514.26 491.98 493.33 83.47 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -83.44 -109.95 -145.76 -184.26 -109.44 -86.41 -33.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -255.30 -362.35 -195.01 -136.14 -311.40 -413.45 -65.48 Net Fixed Assets -142.57 -230.17 -154.01 -57.86 -107.57 -99.89 Net Investments -223.63 -182.51 -110.17 -173.65 -149.92 -269.19 Others 110.90 50.33 69.17 95.37 -53.91 -44.37 Cash from Financing Activity 3.32 -39.99 -241.95 -156.48 -75.66 7.32 25.98 Net Cash Inflow / Outflow 36.18 -17.57 20.24 37.38 -4.51 0.79 10.90 Opening Cash & Equivalents 47.23 64.80 44.56 7.18 11.70 10.90 0.00 Closing Cash & Equivalent 85.40 47.23 64.80 44.56 7.18 11.70 10.90

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 90.29 79.59 68.72 59.74 41.84 30.75 0.00 ROA 11.32% 13.74% 21.39% 32.80% 22.94% 26.40% 13.39% ROE 12.56% 15.70% 26.46% 43.17% 33.40% 39.71% 18.92% ROCE 16.14% 20.99% 34.48% 51.79% 39.15% 46.23% 23.87% Fixed Asset Turnover 1.14 1.28 1.89 2.09 1.97 2.07 1.09 Receivable days 62.77 42.24 47.44 46.80 39.69 57.94 142.49 Inventory Days 64.31 94.20 81.55 66.93 67.95 72.66 151.76 Payable days 70.20 63.97 79.99 87.45 94.44 49.88 86.75 Cash Conversion Cycle 56.88 72.47 49.01 26.27 13.19 80.72 207.50 Total Debt/Equity 0.03 0.02 0.04 0.06 0.13 0.24 0.14 Interest Cover 44.92 54.75 46.45 85.72 36.49 17.39 57.60

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 65.97 80.47 68.16 59.99 46.39 33.18 0.00 ROA 10.02% 13.76% 20.18% 25.62% 21.52% 25.50% 13.39% ROE 14.20% 15.87% 25.21% 33.52% 30.47% 37.80% 18.92% ROCE 18.44% 21.22% 33.41% 45.92% 36.19% 44.55% 23.87% Fixed Asset Turnover 0.81 1.17 1.71 2.09 1.97 2.07 1.09 Receivable days 63.71 42.46 47.25 46.80 39.69 57.94 142.49 Inventory Days 60.62 94.43 81.11 66.93 67.95 72.66 151.76 Payable days 74.38 65.80 79.70 87.45 94.44 49.88 86.75 Cash Conversion Cycle 49.95 71.09 48.66 26.27 13.19 80.72 207.50 Total Debt/Equity 0.05 0.02 0.04 0.06 0.12 0.22 0.14 Interest Cover 28.85 55.45 44.69 79.29 36.48 16.45 57.60

Top Investors:

dsp regular savings fund

icic preduential health care and diaganostic

jasub property holdings llp

jasti property and equity holdings private limited

hdfc trustee company limited - hdfc tax saver fund

sbi life insurance co. ltd

invesco india contra fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Cohance Lifesciences receives five observations from USFDA for Pashamylaram facility
6th Aug 2026, 12:41 PM

USFDA has conducted an inspection from July 27, 2026, to August 5, 2026 at the said facility
Read More
Cohance Lifesciences - Quarterly Results
6th Aug 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback